PanGenex Finalizes Acquisition of Calgenex Corporation
TAMPA, Fla. (Business Wire EON) April 21, 2008 --
PanGenex Corporation (Pink Sheets:PGXC) announces that on April 8th,
2008, the Company completed the acquisition of Calgenex Corporation.
Calgenex develops and markets proprietary formulations to address
specific health conditions. Calgenex has developed a line of
nutraceuticals including Calci-CLEAR™ to
address soft tissue calcification, Omeganol to encourage cholesterol
balancing and the topical application Dermalleve for psoriasis, eczema
and dermatitis.
“Completing the acquisition of Calgenex allows
us to aggressively begin marketing our proprietary nutraceutical product
line through the internet, physician referrals and other retail
platforms. In the near future we will be welcoming very prestigious
physicians to both our Board of Directors and Scientific Advisory Board
as we strive to make a lasting impact throughout the cardiovascular
health industry,” stated Jeff Roman, CEO and
President of PanGenex Corporation.
Calgenex was acquired for 22M shares of restricted common stock. Further
corporate updates and additional information are available on the
Company website at www.PanGenex.com
and www.PinkSheets.com.
About PanGenex Corporation
PanGenex pursues business opportunities in the nutraceutical and
cardiovascular health industries. The Company seeks to develop and
market novel, patented or patent pending, condition specific
nutraceuticals and topical over-the-counter (OTC) drugs and personal
care products. Healthy Solutions from Science and Nature.™
Learn more about Calgenex by visiting: www.Calgenex.com
Disclaimer:
Cautionary Statement about Forward-Looking Statements
This press release contains "forward-looking statements," which are
statements related to future, not past, events. In this context, the
forward-looking statements often include statements regarding our goals,
plans, projections and guidance regarding our financial position,
results of operations, market position, pending and potential future
acquisitions and business strategy, and often contain words such as
"expects," "anticipates," "intends," "plans," "believes," "seeks" or
"will." Any such forward-looking statements are not assurances of future
performance and involve risks and uncertainties that may cause results
to differ materially from those set forth in the statements. These risks
and uncertainties include, among other things, (a) general economic and
business conditions, (b) the level of strategic partner incentives, (c)
the future regulatory environment, (d) our cost of financing, (e) our
ability to complete acquisitions and dispositions and the risks
associated therewith, and (f) our ability to retain key personnel. These
factors, as well as additional factors, could affect our forward-looking
statements. We urge you to carefully consider this information. We
undertake no duty to update our forward-looking statements, including
our earnings outlook.
Post Comment:
Trackback URL: http://eon.businesswire.com/pingpr.php/VGhpci1UaGlyLVBpZ2ctTWFnbi1GYWx1LVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
